The aim of the present study will be to identify different phenotypes of microvascular dysfunction and their associations with the severity of anginal symptoms assessed through the Seattle Angina Questionnaire(SAQ-7).
After administration of unfractionated heparin (100UI/Kg), a special pressure guide (Pressure Wire X, Abbott), equipped with a distal sensor capable of measuring pressure and temperature, will be introduced inside the anterior descending branch (IVA) of the left coronary artery and hyperemia will be induced by intravenous infusion of adenosine. The IMR will be calculated using the thermodilution technique, and is given by the product between the mean distal pressure, in the left anterior descending coronary artery, and the mean transit time (Tmn) during maximal hyperemia. During the procedure, additional coronary physiological indices will be calculated such as: * Quiescent full cycle flow ratio (RFR), - Fractional flow reserve (FFR), * Coronary flow reserve (CFR) In order to identify different phenotypes of microvascular dysfunction, as follows: * Phenotype A: Patients with IMR\>25, CFR \<2 and FFR\>0.80 (concordant pure-microvascular pathological results) * Phenotype B: patients with IMR\>25, CFR\>2 and FFR\>0.80 (increased microvascular hyperemic resistance, maintenance of microvascular reactivity) * Phenotype C: Patients with IMR 25, CFR 2 and FFR\>0.80 (normal hyperemic resistance and reduced reactivity) All these phenotypes can also be combined with pathological FFR measures (\<0.80) (phenotypes A1, B1, C1).
Study Type
OBSERVATIONAL
Enrollment
400
Federico II University of Naples
Naples, Italy
RECRUITING(SAQ-7)
Identify different phenotypes of microvascular dysfunction and their associations with anginal symptom severity assessed through the Seattle Angina Questionnaire (SAQ-7).
Time frame: 12 months
characterization of the severity of angina
To validate the ability of the microvascular resistance index to identify patients who have microvascular disease and its utility in characterizing angina severity. Identify different phenotypes of microvascular dysfunction and their associations with comorbidities, cardiovascular risk factors, and drug therapy. A sub-analysis on the use of different antianginal drugs will be performed to better understand the impact of pharmacotherapy on different microvascular dysfunction phenotypes. Evaluate the health status of patients in different microvascular dysfunction phenotypes through the EQ-5D-5L questionnaire. EQ-5D is a standardized measure of health status developed by the EuroQoL Group in order to provide a simple and generic measure of health for clinical and economic evaluation. Evaluate the state of depression induced by the disease through "The Brief Illness Perception Questionnaire (B-IPQ).
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.